Literature DB >> 20820167

The APOE ɛ4 allele modulates brain white matter integrity in healthy adults.

V Heise1, N Filippini, K P Ebmeier, C E Mackay.   

Abstract

The Apolipoprotein E (APOE) ɛ4 allele is the best-established genetic risk factor for sporadic Alzheimer's disease, and is also associated with structural gray matter and functional brain changes in healthy young, middle-aged and elderly subjects. Because APOE is implicated in brain mechanisms associated with white matter (WM) development and repair, we investigated the potential role played by the APOE polymorphism on WM structure in healthy younger (aged 20-35 years) and older (aged 50-78 years) adults using diffusion tensor imaging. General reduction of fractional anisotropy and increase in mean diffusivity values was found in carriers of the APOE ɛ4 allele relative to non-carriers. No significant interactions between genotype and age were observed, suggesting that differences in WM structure between APOE ɛ4-carriers and non-carriers do not undergo significant differential changes with age. This result was not explained by differences in brain morphology or cognitive measures. The APOE ɛ4 allele modulates brain WM structure before any clinical or neurophysiological expression of impending disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820167     DOI: 10.1038/mp.2010.90

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  77 in total

1.  Effects of APOE promoter polymorphism on the topological organization of brain structural connectome in nondemented elderly.

Authors:  Ni Shu; Xin Li; Chao Ma; Junying Zhang; Kewei Chen; Ying Liang; Yaojing Chen; Zhanjun Zhang
Journal:  Hum Brain Mapp       Date:  2015-08-28       Impact factor: 5.038

Review 2.  Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.

Authors:  Goran Papenberg; Alireza Salami; Jonas Persson; Ulman Lindenberger; Lars Bäckman
Journal:  Neuropsychol Rev       Date:  2015-02-10       Impact factor: 7.444

3.  Structural integrity of the corpus callosum predicts long-term transfer of fluid intelligence-related training gains in normal aging.

Authors:  Dominik Wolf; Florian Udo Fischer; Johanna Fesenbeckh; Igor Yakushev; Irene Maria Lelieveld; Armin Scheurich; Ingrid Schermuly; Lisa Zschutschke; Andreas Fellgiebel
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

Review 4.  White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions.

Authors:  Brian T Gold; Nathan F Johnson; David K Powell; Charles D Smith
Journal:  Biochim Biophys Acta       Date:  2011-07-23

5.  Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.

Authors:  Simona Vuletic; Hal Kennedy; John J Albers; Joep Killestein; Hugo Vrenken; Dieter Lütjohann; Charlotte E Teunissen
Journal:  Mult Scler Relat Disord       Date:  2014-07-01       Impact factor: 4.339

6.  Metastable neural dynamics in Alzheimer's disease are disrupted by lesions to the structural connectome.

Authors:  Thomas H Alderson; Arun L W Bokde; J A Scott Kelso; Liam Maguire; Damien Coyle
Journal:  Neuroimage       Date:  2018-08-18       Impact factor: 6.556

7.  Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Authors:  Paula T Trzepacz; Peng Yu; Phani K Bhamidipati; Brian Willis; Tammy Forrester; Linda Tabas; Adam J Schwarz; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2012-12-17       Impact factor: 21.566

Review 8.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

9.  Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Xi Luo; Yi Zhao; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Sarah A Cooley; Staci Scott; Lee M Cagle; Robert H Paul
Journal:  J Neural Transm (Vienna)       Date:  2015-08-08       Impact factor: 3.575

10.  TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.

Authors:  Martyn McFarquhar; Rebecca Elliott; Shane McKie; Emma Thomas; Darragh Downey; Krisztina Mekli; Zoltan G Toth; Ian M Anderson; J F William Deakin; Gabriella Juhasz
Journal:  Neuropsychopharmacology       Date:  2014-01-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.